Established Products

Our products are used in more than 100 million procedures globally every year. That's equivalent to three patients being injected every second1

1. Data on file. GE Contrast Media Demand; 2019. 

Added value of working with GE Healthcare for your contrast media products

Video Gallery

  • Our investment to continue to help meet your procedural needs

    We have invested more than $240 million globally in the past five years12 to increase our capacity to deliver contrast media, and we will continue to invest in the future.

    Both our primary API production and secondary filling and finishing capacity increased by more than 50% from 2013 to 2018.12

  • Our commitment to meeting your supply of contrast media

    As the global demand for X-ray contrast media products has increased by more than 20% in the last three years13, we have strategically planned ways to help secure our supply of products.

  1. Data on file. GE Contrast Media Demand; 2019
  2. Grainger RG, Thomas AMK. In: Textbook of Contrast Media. Dawson P, Cosgrove DO, Grainger RG, eds. Oxford: Isis Medical Media; 1999.
  3. Widmark JM. Proc (Bayl Univ Med Cent). 2007;20:408-417.
  4. Almén T. Acta Radiol Suppl. 1995;399:2-18.
  5. Greco A et al. Radiology. 1990;176:451-456. 
  6. Data on file. GE Healthcare Market Data; 2018
  7. Marshall G. Radiography. 2008;14:128-134.
  8. Gricar J et al. Radiol Manage. 2007;Sep/Oct:34-42.
  9. Dhaliwal H et al. Int J Life Cycle Assess. 2014;19:1965-1973.
  10. Data on file. GE Healthcare Inspection; 2018
  11. Data on file. GE Healthcare Quality; 2018.
  12. Data on file. GE Healthcare Market Data; 2018
  13. Data on file. GE Healthcare Investment Data; 2018.

    API, active pharmaceutical ingredient.